Hello. It's October 15.

Senescent cells - the damaged, dysfunctional cells that accumulate in your body and drive aging - have a trick. Scientists just found the protein that helps them pull it off: hiding from the immune system that's supposed to clear them.

The rundown:

Let's get to it. 👇

A 47-year study found that physical fitness and strength begin declining around age 35 - even in people who exercise regularly - the decline is gradual until the mid-50s, then accelerates sharply. The implication: the window to build maximal physical capital is smaller than most people assume, and it closes earlier. ScienceDaily

A new Nature Aging study found that chaperone-mediated autophagy - the cellular recycling system that clears damaged proteins - declines with age and this directly causes senescent cells to accumulate - restoring this system in old mice cleared the buildup. The immune system and the recycling system are both failing to remove zombie cells simultaneously. Nature Aging

Just 10 minutes of daily exercise may be enough to meaningfully improve sleep quality - even gentle movement increased slow-wave sleep in older adults. The bar for getting sleep benefit from activity is lower than most advice implies. ScienceDaily

The 2026 Nobel Prize in Physiology or Medicine went to Karl Deisseroth, Peter Hegemann, and Georg Nagel for discovering optogenetics - a technology that uses light to control specific neurons with unprecedented precision - it has already transformed research into Parkinson's, Alzheimer's, and vision loss, and is now being developed for clinical applications. The Nobel validates optogenetics as a platform ready for large-scale clinical translation investment. Nobel Prize

Exercise slowed epigenetic aging and improved cognitive function in breast cancer survivors - a secondary analysis of a randomized trial - the exercise arm showed significantly slower biological aging over 12 months compared to controls. Cancer survivors who exercise regularly don't just feel better. Their cells age more slowly. Fight Aging!

Senescent cells are one of the most well-established drivers of aging. These are cells that have stopped dividing but haven't died - damaged, dysfunctional, and persistently secreting inflammatory signals that damage surrounding tissue. The longevity field calls them zombie cells. Senolytics - a growing drug class - exist specifically to kill them.

But there's been a persistent puzzle: the immune system should be clearing these cells already. That's literally one of its jobs. So why do senescent cells accumulate so dramatically with age?

New research published October 14 answers that. Scientists discovered a protein that helps harmful senescent cells actively hide from the immune system - essentially a cloaking mechanism that allows them to evade the immune surveillance that would normally remove them.

When researchers blocked this protein in mice, the immune system's ability to detect and clear senescent cells was restored. Age-related health problems that are typically associated with senescent cell accumulation improved.

The science breakdown:

Why this matters beyond senolytics: current senolytic drugs work by killing senescent cells directly - a pharmaceutical intervention you take periodically. This discovery points toward a different approach: restoring the body's own immune capacity to clear them naturally. Rather than taking a drug that kills zombie cells, the goal would be removing the protein that lets them hide. The immune system does the rest.

The Turn Back blurb this week about chaperone-mediated autophagy declining with age connects directly: the body has multiple natural senescent cell clearance systems - both immune and cellular recycling - and both are failing simultaneously. The accumulation problem is worse than one mechanism explains.

👉 ScienceDaily

A new study published October 10 found that chronically lonely people lose nearly six years of good health compared to those with strong social connections - measured not just in lifespan, but in disability-free, high-quality years of life.

This is the longevity number that should sit alongside blood pressure and cholesterol on a health risk profile, but rarely does. Social isolation increases the risk of premature death by roughly 30% - comparable to smoking 15 cigarettes a day. This is well-established. The new finding adds precision: it's not just about dying sooner. It's about spending significantly more of your later years in poor health.

The mechanism runs through the same pathways chronic loneliness shares with other major stressors: persistently elevated cortisol, systemic inflammation, disrupted sleep, weakened immune function, and reduced physical activity. Each of these individually accelerates biological aging. Chronic loneliness activates most of them simultaneously, around the clock.

The practical note: longevity protocols that focus entirely on supplements, exercise, and diet while ignoring social connection are optimizing an incomplete model. The evidence for strong relationships as a health intervention - not as a lifestyle choice, but as a measurable biological variable - is as strong as the evidence for most things people are actively managing in their stack.

👉 ScienceDaily

Superpower gives you access to 100+ biomarkers in a single comprehensive panel, at 2,000+ US labs or with a home visit. $199/year. HSA and FSA eligible. Use code STAYIN20OFF to get $20 off.

👉 Check your biomarkers at Superpower

The very first attempt at cellular reprogramming in a human patient is underway - and early results look promising. Business Insider reported this week that Life Biosciences, cofounded by David Sinclair, has dosed patients with ER-100: a gene therapy delivering three Yamanaka reprogramming factors to the eye, designed to reset cells to a more youthful biological state. The target conditions are glaucoma and optic nerve injury. The early read: it appears to be working.

Cellular reprogramming is the longevity technology that has attracted the most billionaire capital over the past five years. Altos Labs ($5-6 billion, backed by Jeff Bezos) is pursuing it across multiple tissue types. NewLimit (Brian Armstrong of Coinbase) just closed a $435 million Series C - with Eli Lilly as a participant, which is the clearest possible signal that this has left the speculative phase. Retro Biosciences (Sam Altman) is running parallel programs in reprogramming and autophagy.

The market reading: when the first human trial produces positive data and Eli Lilly takes a position in a reprogramming startup's Series C in the same year, the asset class has changed. This isn't billionaire science projects anymore. This is pharma making big bets.

👉 Business Insider

This week's Turn Back section includes a study showing fasting's most interesting effects only appear after three days without food. Fung - a nephrologist who has built an evidence-based clinical practice around therapeutic fasting - makes the case for why fasting and insulin management are the most underused tools in metabolic medicine. His thesis about insulin is overstated in places; the fasting chapters are solidly grounded in research and increasingly validated by the literature. If the 3-day fasting finding caught your attention, this is where to start.

👉 Get The Obesity Code